ALCON LABORATORIES (U.K.) LIMITED
ALCON LABORATORIES (U.K.) LIMITED
ALCON LABORATORIES (U.K.) LIMITED
Company Registration Number:
00968373 (England and Wales)
Unaudited statutory accounts for the year ended 31 December 2022
Period of accounts
Start date: 1 January 2022
End date: 31 December 2022
ALCON LABORATORIES (U.K.) LIMITED
Contents of the Financial Statements
for the Period Ended 31 December 2022
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes |
ALCON LABORATORIES (U.K.) LIMITED
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 December 2022
Principal activities of the company
Additional information
Business reviewThe Company is a private company limited by shares, domiciled and incorporated in England,United Kingdom.The profit for the financial year amounts to £212k (2021: £107k).Total shareholders’ funds for the financial year 2022 were £11,683k (2021: £11,471k).Future outlookThe Company is expected to be wound up within the next 2 years after the signing date of thefinancial statements. Due to internal restructuring in the finance department, it was decided toput on hold the project until early 2024.Financial risk management objectives and policies - Liquidity riskGiven the fact that the Company will be liquidated in the near future there are not considered tobe any significant financial risks. The Company will source additional funding from its immediateparent company where required to facilitate the liquidation.
Directors
The directors shown below have held office during the whole of the period from
1 January 2022 to 31 December 2022
Secretary
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
ALCON LABORATORIES (U.K.) LIMITED
Profit And Loss Account
for the Period Ended
2022 | 2021 | |
---|---|---|
| £ | £ |
Administrative expenses: | ( | ( |
Operating profit(or loss): | ( | ( |
Interest receivable and similar income: | | |
Profit(or loss) before tax: | | |
Tax: | ( | |
Profit(or loss) for the financial year: | | |
ALCON LABORATORIES (U.K.) LIMITED
Balance sheet
As at
Notes | 2022 | 2021 | |
---|---|---|---|
| £ | £ | |
Current assets | |||
Debtors: | 3 | | |
Cash at bank and in hand: | | | |
Total current assets: | | | |
Creditors: amounts falling due within one year: | 4 | ( | ( |
Net current assets (liabilities): | | | |
Total assets less current liabilities: | | | |
Total net assets (liabilities): | | | |
Capital and reserves | |||
Called up share capital: | | | |
Profit and loss account: | | | |
Total Shareholders' funds: | | |
The notes form part of these financial statements
ALCON LABORATORIES (U.K.) LIMITED
Balance sheet statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
ALCON LABORATORIES (U.K.) LIMITED
Notes to the Financial Statements
for the Period Ended 31 December 2022
-
1. Accounting policies
Basis of measurement and preparation
These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101 Other accounting policies
Going ConcernIn 2020, the Directors have made the decision to wind up of the Company and accordingly thesefinancial statements have not been prepared on the going concern basis. As a result, all assetsand liabilities which are not expected to be realized have been written off.Interest incomeInterest income is recognised using the effective interest method. When a loan and receivable isimpaired, the Company reduces the carrying amount to its recoverable amount, being theEstimated future cash flow discounted at the original effective interest rate of the instrument,and continues unwinding the discount as interest income.TaxationTax is recognised in the income statement. The current income tax charge is calculated on thebasis of the tax laws enacted or substantively enacted at the balance sheet date in the countrieswhere the Company operates and generates taxable income. Management periodically evaluatespositions taken in tax returns with respect to situations in which applicable tax regulation issubject to interpretation. It establishes provisions where appropriate on the basis of amountsexpected to be paid to the tax authorities.DebtorsDebtors are amounts due from related parties for services performed in the ordinary course ofbusiness. If collection is expected in one year or less (or in the normal operating cycle of thebusiness if longer), they are classified as current assets. If not, they are presented as non-currentassets. Debtors are recognised initially at fair value and subsequently measured at amortised costusing the effective interest method, less provision for impairment.A number of new or amendments became applicable for the current reporting period. The impactof the adoption of the new amendments and the new accounting policies are disclosed below.The amendments to IFRS 9 and IAS 39 Financial Instruments: Recognition and Measurementprovide a number of reliefs, which apply to all loans that are directly affected by interest ratebenchmark reform. When changing the basis for determining contractual cash flows for financialassets and liabilities (including lease liabilities), the reliefs have the effect that the changes, thatare necessary as a direct consequence of IBOR reform and which are considered economicallyequivalent, will not result in an immediate gain or loss in the income statement. The company hasassessed the transition to alternative benchmark rates.Starting from the last contract amendment in 2022, TISONI1Y Sterling Libor rate was applied andthis amendment had no material impact on the company’s financial statements but increasinginterest income.CreditorsCreditors are obligations to pay for goods or services that have been acquired in the ordinarycourse of business from suppliers. Creditors are recognised initially at fair value and subsequentlymeasured at amortised cost using the effective interest method.Cash at bank and in handCash at bank and in hand comprise deposits with banks and bank and cash balances. In thebalance sheet, bank overdrafts are included in borrowings in current liabilities.Critical accounting estimates and judgmentsThe Company did not make any significant judgments and estimates on applying accountingpolicies during the financial year ended 31st December 2022 or 31st December 2021.
ALCON LABORATORIES (U.K.) LIMITED
Notes to the Financial Statements
for the Period Ended 31 December 2022
-
2. Employees
2022 2021 Average number of employees during the period 0 0
ALCON LABORATORIES (U.K.) LIMITED
Notes to the Financial Statements
for the Period Ended 31 December 2022
3. Debtors
2022 | 2021 | |
---|---|---|
£ | £ | |
Other debtors | | |
Total | | |
ALCON LABORATORIES (U.K.) LIMITED
Notes to the Financial Statements
for the Period Ended 31 December 2022
4. Creditors: amounts falling due within one year note
2022 | 2021 | |
---|---|---|
£ | £ | |
Trade creditors | | |
Total | | |